Copyright
©The Author(s) 2024.
World J Gastroenterol. Mar 14, 2024; 30(10): 1431-1449
Published online Mar 14, 2024. doi: 10.3748/wjg.v30.i10.1431
Published online Mar 14, 2024. doi: 10.3748/wjg.v30.i10.1431
Figure 3 Increased serotonin receptor 2B and transient receptor potential vanilloid type 1 levels in the irritable bowel syndrome with diarrhea group.
A: Immunohistochemical staining revealed the expression of the serotonin receptor 2B (5-HT2B receptor) in the colon tissue in irritable bowel syndrome with diarrhea (IBS-D) rats and normal control rats; Magnification 20 ×; B: Expression of 5-HT2B receptor protein in the colonic mucosa layer of the IBS-D group and normal control group; C: Expression of 5-HT2B receptor protein in the colonic muscular layer of the IBS-D group and normal control group; D: Levels of 5-HT2B receptor mRNA in the colonic mucosa layer from the IBS-D group and normal control group; E: Levels of 5-HT2B receptor mRNA in the colonic muscular layer from the IBS-D group and normal control group; F: Immunohistochemical staining showing the expression of transient receptor potential vanilloid type 1 (TRPV1) in the colon tissue in IBS-D rats and normal control rats. Magnification 20 ×; G: Levels of TRPV1 mRNA in the colonic mucosa layer from the IBS-D group and normal control group; H: Levels of TRPV1 mRNA in the colonic muscular layer from the IBS-D group and normal control group. aP < 0.05, cP < 0.001. IBS-D: Irritable bowel syndrome with diarrhea; 5-HT2B: Serotonin receptor 2B; TRPV1: Transient receptor potential vanilloid type 1.
- Citation: Li ZY, Mao YQ, Hua Q, Sun YH, Wang HY, Ye XG, Hu JX, Wang YJ, Jiang M. Serotonin receptor 2B induces visceral hyperalgesia in rat model and patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2024; 30(10): 1431-1449
- URL: https://www.wjgnet.com/1007-9327/full/v30/i10/1431.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i10.1431